Niki BioSolutions, Inc. Sale Leaseback Transaction, Gross Proceeds, Financing Activities
Niki BioSolutions, Inc. (NIKI) reported Sale Leaseback Transaction, Gross Proceeds, Financing Activities of $4.00 million for the 9-month period ending 2026-02-28, per its POS AM filed 2026-05-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:SaleLeasebackTransactionGrossProceedsFinancingActivities · last filed 2026-05-29
- 2026-02-28: Sale Leaseback Transaction, Gross Proceeds, Financing Activities 9 month $4.00M.
- 2025-08-31: Sale Leaseback Transaction, Gross Proceeds, Financing Activities $4.00M.
| Period end | Sale Leaseback Transaction, Gross Proceeds, Financing Activities | Sale Leaseback Transaction, Gross Proceeds, Financing Activities 9 month |
|---|---|---|
| 2026-02-28 | $4.00M POS AM · filed 2026-05-29 | |
| 2025-08-31 | $4.00M S-4/A · filed 2026-05-11 |